Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells

Mototsugu Oya, Masafumi Ohtsubo, Atsushi Takayanagi, Masaaki Tachibana, Nobuyoshi Shimizu, Masaru Murai

研究成果: Article査読

138 被引用数 (Scopus)

抄録

TRAIL has gained much attention for its specific induction of apoptosis in cancer cells but not in normal cells. This phenomenon has been explained thus: that cancer cells dominantly express death receptors while normal cells express decoy receptors. However, recent reports have shown that some cancer cell lines are resistant to TRAIL-induced apoptosis despite the absence of decoy receptors and the presence of death receptors. This suggested the existance of an inhibitory factor. We herein showed that NF-κB is a key molecule underlying the TRAIL-resistant mechanism in renal cell carcinoma (RCC) cell lines. We observed that NF-κB is constitutively activated in resistant cell lines. Forced expression of antisense cDNA of IκBα, a specific inhibitor of NF-κB, in TRAIL-sensitive cell lines with a low NF-κB activity result in constitutive activation of NF-κB and resistance to TRAIL-induced apoptosis. Adenoviral expression of a stable form of IκBα in the TRAIL-resistant cell lines induced apoptosis. These data suggest that RCC can be classified into two subsets: TRAIL-sensitive RCC with a low NF-κB activity and TRAIL-resistant RCC with constitutively activated NF-κB. In the former group TRAIL can be a treatment option, while in the latter group a molecular approach targeting NF-κB appears to be a promising therapy.

本文言語English
ページ(範囲)3888-3896
ページ数9
ジャーナルOncogene
20
29
DOI
出版ステータスPublished - 2001 6 28

ASJC Scopus subject areas

  • 分子生物学
  • 遺伝学
  • 癌研究

フィンガープリント

「Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル